Company: BIAF
Filing Date: 2025-06-02
Form Type: DEFA14A
Source: 0001641172-25-013284
Chunk: 0

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-06-02
Form: DEFA14A
Chunk 0
---
<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

(Rule 14a-101)

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934</div>

Filed by the Registrant ☒

Filed by a Party other than the Registrant ☐

Check the appropriate box:

| ☐ | Preliminary Proxy Statement                      |
| ☐ | Confidential, for Use of the Commission Only (as 
 permitted by Rule 14a-6(e)(2))                   |
| ☐ | Definitive Proxy Statement                       |
| ☒ | Definitive Additional Materials                  |
| ☐ | Soliciting Material Pursuant to §240.14a-12      |

<div align='center'>bioAffinity Technologies, Inc.

(Exact Name of Registrant as Specified in its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)</div>

Payment of Filing Fee (Check the appropriate box):

| ☒ | No fee required.                                                           |
| ☐ | Fee paid previously with                                                   
 preliminary materials.                                                     |
| ☐ | Fee computed on table in                                                   
 exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11. |